O002/#43 Randomized Phase 3 Study of Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer (Aec): Subgroup Analysis of Patients with Dna Mismatch Repair Deficient (Dmmr) Tumors

AuthID
P-00V-TAV
20
Author(s)
Makker, V
·
Colombo, N
·
Casado Herráez, A
·
Santin, A
·
Colomba, E
·
Fujiwara, K
·
Pignata, S
·
Banerjee, S
·
Monk, B
·
Ushijima, K
·
Penson, R
·
Kristeleit, R
·
Fabbro, M
·
Orlando, M
·
Mackay, H
·
Ren, M
·
Orlowski, R
·
Dutta, L
·
Lorusso, D
Document Type
Proceedings Paper
Year published
2021
Published
in Oral Abstracts
Indexing
Publication Identifiers
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.